The EPS projection of Globant S.A. (NYSE:GLOB) for quarter ended 2016-09-30 is $0.31. Last week, the projection for EPS was $0.31 against target of $0.31, a month earlier. While 2-months ago, this projection was $0.31 versus forecast of $0.31a quarter months earlier, posting a deviation of 0%.
Globant S.A. (NYSE:GLOB) posted that 18 days earlier, the share price was revised 0 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for Globant S.A. (NYSE:GLOB) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.
Globant S.A. (NYSE:GLOB) EPS target was $0.31 for the quarter closed 1. It was based on 2 calls. As on 2016-05-09 the EPS was $0.23. The change was $0.02, posting a deviation of 9.52%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
Globant S.A. (NYSE:GLOB) sales prediction for the fiscal 2016 stands at $83.082 and the median estimate is at $83.765. Almost 4 analysts gave sales target.
Among this, the highest sales estimate is $84.4 while the lowest target is $80.4 showing standard deviation of 1.813%.
As many as 4 analysts have positive sales targets revision while 4 reduced sales estimates, posting a deviation of 0.531%.
Last month, 4 experts have positive sales number revision. Also, 4 research groups lowered the sales projections, posting a deviation of 0.531%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast, posting a deviation of -1.951%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...